Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 03-2002 | |
| Sales | 0 | 0 | 0 | 0 | 161,266 |
| Cost of Goods | N/A | N/A | N/A | N/A | 150,071 |
| Gross Profit | N/A | N/A | N/A | N/A | 11,195 |
| Operating Expenses | 61,470 | 36,904 | 28,889 | 20,994 | 14,878 |
| Operating Income | -61,470 | -36,904 | -28,889 | -20,994 | -3,612 |
| Interest Expense | 0 | 0 | 0 | 0 | 3,428 |
| Other Income | 65 | -4 | 597 | 180 | -340 |
| Pre-tax Income | -61,405 | -36,908 | -28,292 | -20,814 | -7,380 |
| Income Tax | N/A | N/A | N/A | N/A | 12,384 |
| Net Income Continuous | -61,405 | -36,908 | -28,292 | -20,814 | -19,764 |
| Net Income | $-61,405 | $-36,908 | $-28,292 | $-20,814 | $-19,764 |
| EPS Basic Total Ops | -2.84 | -4.49 | -24.16 | -18.14 | -3.08 |
| EPS Basic Continuous Ops | -2.84 | -3.86 | -19.50 | -15.03 | -3.08 |
| EPS Diluted Total Ops | -2.84 | -4.49 | -24.16 | -18.14 | -3.08 |
| EPS Diluted Continuous Ops | -2.84 | -3.86 | -19.50 | -15.03 | -3.08 |
| EPS Diluted Before Non-Recurring Items | -2.84 | -4.49 | N/A | N/A | N/A |
| EBITDA(a) | $-60,713 | $-36,716 | $-28,889 | $-20,994 | $672 |